Amersham to Pay Nearly $1B for Pharmacia s Stake in Amersham Biosciences | GenomeWeb

NEW YORK, March 12 - Amersham on Tuesday said it plans to buy Pharmacia's 45-percent stake in Amersham Biosciences for £704 million, or roughly $992 million.

The transaction, which is subject only to finalization of a definitive contract, will give Amersham full ownership of the business. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.